$123.96
0.0% Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
GSK Completes $10.6 Billion Acquisition of Nuvalent
GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share
GSK Unit Launches Tender Offer for Nuvalent Acquisition
Overview
52-week range
$71
$113
100% of range
Avg surprise (last 3)
-3.2%
Avg reaction (last 2)
+2.8%
50% positive
Latest IV / EM
33%
EM ±2.4% · $125 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-1.39 | $-1.35 | -3.0% | -17.8% | -1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.70 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-1.31 | $-1.27 | -3.1% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-1.18 | $-1.14 | -3.5% | — | +7.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-1.28 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.88 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.69 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.59 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.51 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$1.44 | -$1.31 | -9.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-119M | — | $-113M | $-105M | $-95M | — | $-76M | $-65M |
| Net income | $-109M | — | $-122M | $-100M | $-85M | — | $-84M | $-57M |
| EPS (diluted) | $-1.39 | — | $-1.70 | $-1.39 | $-1.18 | — | $-1.28 | $-0.88 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $160M | $262M | $116M | $127M | $121M | $146M | $369M | $78M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $1.31B | $1.39B | $957M | $1.02B | $1.09B | $1.13B | $1.18B | $666M |
| Total assets | $1.33B | $1.41B | $980M | $1.04B | $1.11B | $1.14B | $1.19B | $675M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $157M | $164M | $135M | $101M | $95M | $72M | $68M | $38M |
| Total equity | $1.17B | $1.25B | $845M | $940M | $1.01B | $1.07B | $1.12B | $637M |